MedTrace Logo

Endoscopic Ethanol Ablation of Communicating Pancreatic Cystic Neoplasms

NCT01057355 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2014-09-19

No results posted yet for this study

Summary

Pancreatic cysts are common, and some pancreas cysts have malignant potential. Usual treatment of these cysts is either observation or surgical removal of part or all of the pancreas. Minimally invasive treatment via endoscopy has been described, using endoscopic ultrasound (EUS) guided ethanol injections. Such studies exclude cysts that communicate with the main pancreatic duct, to avoid burning the main pancreatic duct with ethanol. In this study, pancreas cysts communicating with the main pancreas duct are treated with ethanol via endoscopic retrograde cholangiopancreatography (ERCP) and/or EUS.

Conditions

  • Neoplasms, Cystic, Mucinous, and Serous
  • Pancreatic Neoplasms
  • Ultrasonography, Interventional

Interventions

PROCEDURE

EUS and/or ERCP with ethanol injections of pancreatic cyst

Lavage of cyst with 80% ethanol

Sponsors & Collaborators

Principal Investigators

  • Mark Topazian, M.D. · Mayo Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2013-06-30
Completion
2013-06-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01057355 on ClinicalTrials.gov